Predicting Growth of Solid Renal Masses Under Active Surveillance

Por Crispen, Paul L., Wong, Yu-Ning, Greenberg, Richard E., Chen, David Y.T., Uzzo, Robert G.
Publicado em 2008

Randomized Controlled Trial of Expressive Writing for Patients With Renal Cell Carcinoma

Por Milbury, Kathrin, Spelman, Amy, Wood, Christopher, Matin, Surena F., Tannir, Nizar, Jonasch, Eric, Pisters, Louis, Wei, Qi, Cohen, Lorenzo
Publicado em 2014

Effect of comorbidity on risk of venous thromboembolism in patients with renal cell carcinoma()

Por Smith, Angela B., Horvath-Puhó, Erzsébet, Nielsen, Matthew E., Lash, Timothy L., Baron, John A., Sørensen, Henrik T.
Publicado em 2014

Managing metastatic renal cell carcinoma-challenges, pitfalls, and outcomes in the real world

Por Kumar, Karnam Ashok, Sadashivudu, Gundeti, Krishnamani, K. V., Linga, Vijay Gandhi, Maddali, Lakshmi Srinivas, Digumarti, Raghunadha Rao
Publicado no Indian J Med Paediatr Oncol (2016)

Accelerated Methotrexate, Vinblastine, Doxorubicin, and Cisplatin Is Safe, Effective, and Efficient Neoadjuvant Treatment for Muscle-Invasive Bladder Cancer: Results of a Multicenter Phase II Study...

Por Plimack, Elizabeth R., Hoffman-Censits, Jean H., Viterbo, Rosalia, Trabulsi, Edouard J., Ross, Eric A., Greenberg, Richard E., Chen, David Y.T., Lallas, Costas D., Wong, Yu-Ning, Lin, Jianqing, Kutikov, Alexander, Dotan, Efrat, Brennan, Timothy A., Palma, Norma, Dulaimi, Essel, Mehrazin, Reza, Boorjian, Stephen A., Kelly, William Kevin, Uzzo, Robert G., Hudes, Gary R.
Publicado em 2014

Establishment and characterization of a highly immunogenic human renal carcinoma cell line

Por Prattichizzo, Clelia, Gigante, Margherita, Pontrelli, Paola, Stella, Alessandro, Rocchetti, Maria Teresa, Gigante, Maddalena, Maiorano, Eugenio, Herr, Wolfgang, Battaglia, Michele, Gesualdo, Loreto, Ranieri, Elena
Publicado no Int J Oncol (2016)

Cytoreductive Surgery in the Management of Renal Tumours: Rationale, Current Evidence and Future Perspectives

Por Khochikar, Makarand V
Publicado no Indian J Surg Oncol (2016)

Cystic renal cell carcinoma carries an excellent prognosis regardless of tumor size

Por Winters, Brian R., Gore, John L., Holt, Sarah K., Harper, Jonathan D., Lin, Daniel W., Wright, Jonathan L.
Publicado no Urol Oncol (2015)

Does Bone-targeted Therapy Benefit Patients with Metastatic Renal Cell Carcinoma?

Por Wong, Emily C.L., Kapoor, Anil
Publicado no Transl Oncol (2019)

Colorectal and Other Cancer Risks for Carriers and Noncarriers From Families With a DNA Mismatch Repair Gene Mutation: A Prospective Cohort Study

Por Win, Aung Ko, Young, Joanne P., Lindor, Noralane M., Tucker, Katherine M., Ahnen, Dennis J., Young, Graeme P., Buchanan, Daniel D., Clendenning, Mark, Giles, Graham G., Winship, Ingrid, Macrae, Finlay A., Goldblatt, Jack, Southey, Melissa C., Arnold, Julie, Thibodeau, Stephen N., Gunawardena, Shanaka R., Bapat, Bharati, Baron, John A., Casey, Graham, Gallinger, Steven, Le Marchand, Loïc, Newcomb, Polly A., Haile, Robert W., Hopper, John L., Jenkins, Mark A.
Publicado em 2012

Improvement of renal function by changing the bone-modifying agent from zoledronic acid to denosumab

Por Yamasaki, Mutsushi, Yuasa, Takeshi, Uehara, Sho, Fujii, Yasuhisa, Yamamoto, Shinya, Masuda, Hitoshi, Fukui, Iwao, Yonese, Junji
Publicado no Int J Clin Oncol (2016)

Aldehyde dehydrogenase 1 expression in primary and metastatic renal cell carcinoma: an immunohistochemistry study

Por Abourbih, Samuel, Sircar, Kanishka, Tanguay, Simon, Kassouf, Wassim, Aprikian, Armen, Mansure, Jose, Brimo, Fadi
Publicado em 2013

Unusual Metastases in Renal Cell Carcinoma: A Single Institution Experience and Review of Literature

Por Villarreal-Garza, Cynthia, Perez-Alvarez, Sandra I., Gonzalez-Espinoza, Ivan R., Leon-Rodriguez, Eucario
Publicado no World J Oncol (2010)

Assessment of nivolumab benefit–risk profile of a 240-mg flat dose relative to a 3-mg/kg dosing regimen in patients with advanced tumors

Por Zhao, X., Suryawanshi, S., Hruska, M., Feng, Y., Wang, X., Shen, J., Vezina, H. E., McHenry, M. B., Waxman, I. M., Achanta, A., Bello, A., Roy, A., Agrawal, S.
Publicado no Ann Oncol (2017)

Phase II Presurgical Feasibility Study of Bevacizumab in Untreated Patients With Metastatic Renal Cell Carcinoma

Por Jonasch, Eric, Wood, Christopher G., Matin, Surena F., Tu, Shi-Ming, Pagliaro, Lance C., Corn, Paul G., Aparicio, Ana, Tamboli, Pheroze, Millikan, Randall E., Wang, Xuemei, Araujo, John C., Arap, Wadih, Tannir, Nizar
Publicado no J Clin Oncol (2009)

Molecular Characterization and Putative Pathogenic Pathways of Tuberous Sclerosis Complex–Associated Renal Cell Carcinoma

Por Park, Jeong Hwan, Lee, Cheol, Chang, Mee Soo, Kim, Kwangsoo, Choi, Seongmin, Lee, Hyunjung, Lee, Hyun-Seob, Moon, Kyung Chul
Publicado no Transl Oncol (2018)

Development and validation of a microRNA‐based diagnostic assay for classification of renal cell carcinomas

Por Spector, Yael, Fridman, Eddie, Rosenwald, Shai, Zilber, Sofia, Huang, Yajue, Barshack, Iris, Zion, Orit, Mitchell, Heather, Sanden, Mats, Meiri, Eti
Publicado no Mol Oncol (2013)

let-7b and let-7c are determinants of intrinsic chemoresistance in renal cell carcinoma

Por Peng, Jingtao, Mo, Ren, Ma, Jian, Fan, Jie
Publicado no World J Surg Oncol (2015)

Systemic Therapy for Metastatic Non-Clear Cell Renal Cell Carcinoma: Recent Progress and Future Directions

Por Chowdhury, Simon, Matrana, Marc, Tsang, Christopher, Atkinson, Bradley, Choueiri, Toni K., Tannir, Nizar M.
Publicado em 2011

Surgical approach and the use of lymphadenectomy and adrenalectomy among patients undergoing radical nephrectomy for renal cell carcinoma

Por Filson, Christopher P., Miller, David C., Colt, Joanne S., Ruterbusch, Julie, Linehan, W. Marston, Chow, Wong-Ho, Schwartz, Kendra
Publicado em 2011